GlassScriptPhysician profile
Amit Kalra
NPI 1467673467
$6,113.15
in general payments reported to CMS, 2019-2025
46 companies · $1,099 in 2025
The $1,099 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $452 · 2021: $1,009 · 2022: $1,021 · 2023: $966 · 2024: $932 · 2025: $1,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,907 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,906.82 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $816.77 | 2019-2025 | |
| Amgen INC. | $674.39 | 2019-2025 | Repatha, Repatha |
| Harmony Biosciences LLC | $510.59 | 2022-2025 | Wakix |
| Kowa Pharmaceuticals America, INC. | $425.38 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $335.24 | 2022-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $270.97 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $259.05 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $234.92 | 2019-2024 | Jardiance |
| Cvrx, INC. | $222.51 | 2021-2024 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $217.96 | 2022-2025 | Onpattro |
| Astrazeneca Pharmaceuticals LP | $212.21 | 2019-2025 | Wainua |
| Avadel Cns Pharmaceuticals, LLC | $202.12 | 2024-2025 | Lumryz |
| Pfizer INC. | $176.91 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $161.47 | 2019-2025 | |
| Boston Scientific Corporation | $129.18 | 2019-2025 | Watchman Flx, Watchman |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $88.81 | 2019-2021 | |
| Daiichi Sankyo INC. | $81.63 | 2022-2024 | Injectafer |
| Sanofi-Aventis U.S. LLC | $71.85 | 2019-2022 | |
| Abbott Laboratories | $67.62 | 2021-2024 | Jot Dx, Amplatzer Amulet |
| Axsome Therapeutics, INC. | $62.62 | 2023-2025 | Sunosi |
| Heartflow, INC. | $61.86 | 2024-2025 | |
| Orthofix Medical, INC. | $56.92 | 2023 | Physio-Stim |
| Resmed Corp | $55.44 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.96 | 2020-2024 | Lifevest |
| Bridgebio Pharma, INC. | $53.14 | 2025 | Attruby |
| Regeneron Healthcare Solutions, INC. | $46.07 | 2019-2024 | Evkeeza |
| Edwards Lifesciences Corporation | $44.88 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Atricure, INC. | $44.32 | 2024-2025 | Atriclip Laa Exclusion System |
| Baxter Healthcare | $42.82 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals, LTD. | $41.75 | 2022-2023 | Arcalyst |
| Inspire Medical Systems, INC. | $39.93 | 2024 | Inspire |
| Arbor Pharmaceuticals, INC. | $33.91 | 2020-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $31.35 | 2024 | Arcalyst |
| 3b Medical, INC. | $30.06 | 2025 | Luna |
| Abiomed | $28.61 | 2023 | Impella |
| Acarix USA INC. | $28.25 | 2023 | Cadscor System |
| Bayer Healthcare Pharmaceuticals INC. | $28.13 | 2021-2025 | |
| Philips North America LLC | $25.51 | 2025 | Extended Holter |
| Recor Medical INC | $23.08 | 2024 | Paradise Renal Denervation System |
| Novo Nordisk INC | $21.95 | 2025 | Wegovy |
| Impulse Dynamics (USA) INC. | $21.08 | 2022 | |
| Lilly USA, LLC | $18.97 | 2025 | Zepbound |
| Esperion Therapeutics, INC. | $16.66 | 2024 | Nexletol |
| Kestra Medical Technology Services, INC. | $14.79 | 2025 | Assure Wcd |
| Altathera Pharmaceuticals LLC | $14.33 | 2024 | Sotalol Hydrochloride |
| Gilead Sciences, INC. | $12.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Kalra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.